Status:
TERMINATED
Intra-arterial Magnesium Administration for Acute Stroke
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Acute Stroke
Eligibility:
All Genders
21-95 years
Phase:
PHASE1
PHASE2
Brief Summary
Stroke is the second leading cause of death and the leading cause of adult disability worldwide. This investigation will address the safety and feasibility of directed, intra-arterial Magnesium measur...
Eligibility Criteria
Inclusion
- Patient with acute cerebral ischemia due to ICA or MCA occlusion,
- Patient's clinical attending physician plans mechanical embolectomy procedure as part of routine clinical care.
- Age 21-95.
Exclusion
- Severe renal impairment with creatinine 3.0 or higher,
- Myasthenia gravis,
- Second or third degree heart block without a pacemaker in place,
- Technical inability to navigate microcatheter to target clot,
- Patient already enrolled in another experimental treatment trial. Exclusion criteria 1-3 are all contraindications to magnesium therapy.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01502761
Start Date
March 1 2012
End Date
May 1 2016
Last Update
August 28 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals
Los Angeles, California, United States, 900094
2
University of Southern California University and LA County Hospitals
Los Angeles, California, United States, 90033